ENTITY
Polaris Group

Polaris Group (6550 TT)

21
Analysis
Health CareTaiwan
Polaris Group of TW researches and develops biological drugs for cancer, small molecular drugs, and other diagnostic reagents. The Company focuses on hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, and acute myeloid leukemia fields. Polaris Group conducts businesses in Taiwan and California.
more
Refresh
Company Presentation01 Apr 2024 15:30
Company Presentation21 Dec 2023 14:00
Company Presentation11 Sep 2023 14:30
Company Presentation09 Jun 2023 15:00
Company Presentation10 Jan 2024 07:30
x